MEI Pharma (MEIP) PT Lowered to $4.50 at Oppenheimer
Tweet Send to a Friend
Oppenheimer lowered its price target on MEI Pharma (NASDAQ: MEIP) to $4.50 (from $6.50) while maintaining an Outperform rating.Analyst Leah ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
